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Miller-Dieker syndrome involves a severe type of lissencephaly, which is caused by defects in the lissencephaly gene (LIS1). We re-
port the case of a female infant with der(17)t(12;17)(q24.33;p13.3)pat caused by an unbalanced segregation of the parental bal-
anced translocation of 17p with other chromosomes. The proband presented with facial dysmorphism, arthrogryposis, and intra-
uterine growth retardation. Most cases of Miller-Dieker syndrome have a de novo deletion involving 17p13.3. When Miller-Dieker 
syndrome is caused by an unbalanced translocation, mild-to-severe phenotypes occur according to the extension of the involved 
partner chromosome. However, a pure partial monosomy derived from a paternal balanced translocation is relatively rare. In this 
case, the submicroscopic cryptic deletion in the proband was initially elucidated by FISH, and karyotype analysis did not reveal ad-
ditional chromosome abnormalities such as translocation. However, a family history of recurrent pregnancy abnormalities strongly 
suggested familial translocation. Sequential G-banding and FISH analysis of the father’s chromosomes showed that the segment 
of 17p13.3→pter was attached to the 12qter. Thus, we report a case that showed resemblance to the findings in cases of a nearly 
pure 17p deletion, derived from t(12;17), and delineated by whole genome array comparative genomic hybridization (CGH). If such 
cases are incorrectly diagnosed as Miller-Dieker syndrome caused by de novo 17p13.3 deletion, the resultant improper genetic 
counseling may make it difficult to exactly predict the potential risk of recurrent lissencephaly for successive pregnancies. 
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INTRODUCTION
Miller-Dieker syndrome (MDS) is a multiple-malforma-
tion syndrome in which the patients show severe lissenceph-
aly with facial dysmorphism at birth. Lissencephaly varies 
in severity from agyria to pachygyria and is linked to defects 
in the lissencephaly gene (LIS1), which is located in 17p13.3 
[1]. In patients with MDS, the loss of the LIS1 gene can oc-
cur by deletion [2], ring chromosome formation [3], or 
transmission of a parental chromosome with an unbalanced 
translocation, including transmission of chromosome 
17p13.3 [4]. In approximately 80% of the cases of MDS in 
infants, the disease is believed to be caused by a de novo de-
letion, and the remaining cases are caused by inheritance [5]. 
In the case of a parental balanced translocation, the chromo-
somes of the offspring usually show an unbalanced translo-
cation combined with partial trisomy of another autosomal 
segment.
Various 17p13.3 microdeletions inherited from a parent 
with a balanced translocation of chromosome 17 and an-
other chromosome have been reported [4, 6]. Most patients 
with an unbalanced translocation show a combination of 50     www.kjlm.org
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the findings of MDS and additional unique phenotypes be-
cause of the involvement of segments of various autosomes.
In this report, we report the findings for a female infant 
who had der(17)t(12;17)(q24.33;p13.3)pat showing a nearly 
pure large deletion (~4.6 Mb) involving 17p13→pter without 
evidence of duplication of 12q24.33→qter, which was con-
firmed by high density array comparative genome hybrid-
ization (CGH). Recently, Grosso et al. [7] also reported a 
case of MDS with periventricular nodular heterotopia caused 
by an unbalanced t(12;17)(q24.31;p13.3) translocation. Their 
case had a relatively large duplication (~11 Mb) of 12q24.31 
→qter, but our case showed no definite duplication of 12q in 
the array CGH analysis.
Our case could have been misdiagnosed as a classic case 
of MDS resulting from the deletion of 17p13.3→pter because 
the smallest segment of 12q24.33→qter according to the lit-
eratures was involved. If such patients are incorrectly diag-
nosed with MDS caused by de novo 17p13.3 deletion, the 
resultant improper genetic counseling may make it difficult 
to exactly predict the potential risk of recurrent lissenceph-
aly for successive pregnancies.
CASE REPORT
1. Clinical presentation
The female patient was born to a healthy G4P2 mother 
and a healthy non-consanguineous father at 35 + 5 weeks of 
gestation by cesarean delivery because of preterm labor and 
intrauterine growth retardation. The parents’ first child was 
diagnosed with lissencephaly after birth and died at 3 months 
of age. The second baby was aborted following the diagno-
sis of a brain anomaly by fetal ultrasound.
The patient was their third baby and was diagnosed with 
ventriculomegaly during the antepartum period. The birth 
weight was 1,680 g (<3rd percentile), the length of the baby 
was 42.3 cm (<3rd percentile), and the head circumference 
was 30 cm (3rd–10th percentile). At birth, she was noted to 
have facial dysmorphism, including prominent frontal boss-
ing, a high nasal bridge, low-set ears, a thin inferior lip, mi-
crognathia, and arthrogryposis. On the 3rd day after birth, 
she was diagnosed with symptomatic patent ductus arterio-
sus by echocardiography. Neuromotor delay with marked 
generalized hypotonia was observed. An electroencephalo-
gram showed diffuse brain dysfunction, and magnetic reso-
nance imaging (MRI) showed lissencephaly with band het-
erotopia and agenesis of the corpus callosum (Fig. 1). At 5 
months of age, she was taken to the emergency room be-
cause of generalized tonic seizures and showed failure to 
thrive. The parents had no history of epilepsy or neurologic 
problems.
2. Cytogenetic and molecular studies
Conventional cytogenetic analysis of the proband revealed 
a possible abnormal karyotype [46,XX,del(17)(p13)] (Fig. 
2A). Cytogenetic analysis was also performed on the pro-
band’s parents because the recurrent abnormal phenotypes 
during the 3 consecutive pregnancies strongly suggested 
that MDS in this case might have resulted from an unbal-
anced segregation of the parental balanced translocation of 
17p with other chromosomes. The mother’s karyotype was 
normal.
Cytogenetic analysis of the proband’s father showed a 
shortened p-arm of chromosome 17 (Fig. 2B), which strongly 
suggested a balanced translocation of 17p and another chro-
mosome. However, the small translocated telomeric seg-
ments of chromosome 17 could not be definitively identi-
fied by conventional cytogenetic analysis.
In order to identify the position where the terminal seg-
ment of chromosome 17p13.3→pter was translocated, FISH 
with a Miller-Dieker/lissencephaly region probe (Vysis, Ab-
bott Laboratories, Abbott Park, IL, USA) was performed on 
the same G-banded metaphase chromosomes according to 
the manufacturer’s instructions. The MDS probe signal 
(17p13.3) was detected on chromosome 12qter, indicating 
an unbalanced segregation of t(12;17) (Fig. 3). Further char-
acterization of the size and boundaries of the cytogenetic 
abnormalities of the proband was performed using Human 
Fig. 1. T2-weighted brain magnetic resonance imaging showing lissenceph-
aly with band heterotopia and agenesis of the corpus callosum.Kim YJ, et al.  •  Familial Miller-Dieker Syndrome
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Genome CGH Microarray Kit 244 (Agilent Technologies, 
Palo Alto, CA, USA), which consists of approximately 
244,000 arrayed 60-base oligonucleotide-probes that span 
both coding and non-coding sequences with an average 
spatial resolution of about 15 kb. Array CGH showed about 
a 4.6-Mb deletion involving 17p13.3, but it did not show 
duplication at 12q [arr17p13.3p13.2 (28,969–4,653,156)×1 
pat] (Fig. 4).
DISCUSSION
Our case showed a deletion involving 17p13.3→pter and a 
severe clinical phenotype of MDS, including lissencephaly 
with band heterotopia, corpus callosum agenesis, peculiar 
facial morphology, cardiac defects, and limb anomalies. The 
deletion in 17p13.3→pter in our case included simultaneous 
deletion of the platelet-activating factor acetylhydrolase 1b, 
regulatory subunit 1 (PAFAH1B1) gene (previously called 
LIS1), and the tyrosine 3-monooxygenase/tryptophan 5-mo-
nooxygenase activation protein, epsilon polypeptide 
(YWHAE). Lissencephaly is associated with the loss or mu-
tation of the PAFAH1B1 gene, which contributes to neuro-
nal migration during embryological development, and ad-
ditional loss of the v-crk sarcoma virus CT10 oncogene ho-
molog (avian) (CRK) and YWHAE genes. These genes are 
telomeric to the PAFAH1B1 gene and contribute to cortical 
development and the severity of MDS [8].
Grosso et al. [7] reported a case of MDS with periventric-
ular nodular heterotopia caused by an unbalanced t(12;17)
(q24.31;p13.3) translocation, which showed a 3.7-Mb dele-
tion at 17p13.3→pter and a duplication of about 11 Mb at 
12q24.31→qter. Our case showed a 4.6-Mb deletion involving 
17p.13.3→pter and no identifiable duplication at 12q24.33. 
The phenotypes of our case were similar to those of the case 
reported by Grosso et al. [7], except for cortical heterotopia. 
Cortical heterotopias are relatively uncommon in MDS, but 
if present, they are usually in the form of subcortical hetero-
topias [9]. Periventricular heterotopias have been described 
Fig. 3. (A) Proband’s metaphase FISH results. One orange and 2 green signals indicate loss of 17p13.3. (B) Sequential G-banding (left) and FISH (right) performed 
on her father’s metaphase chromosomes. G-banded metaphase with arrows indicating chromosome 12 and 17. Note that an orange signal of 17p13.3 is observed 
in chromosome 12q.
A B
Fig. 2. (A) Results of presumptive karyotype analysis of the proband [46,XX,del(17)(p13)] showing deletion of 17p.13→pter (arrow). (B) Results of presumptive 
karyotype analysis of the proband’s father [46,XY,t(12;17)(q24.33;p13)].
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in MDS. However, the YWHAE gene has been recently re-
ported to contribute to periventricular heterotopic malfor-
mation [10].
Our case showed no definite duplication of 12q in the 
high-resolution array CGH, and there were no recognizable 
phenotypic features of a partial duplication of 12q24.33→ 
qter. A phenotype for trisomy 12q has been described on 
the basis of the size differences of the duplicated 12q. Chro-
mosome 12q duplication syndrome has common clinical 
features, including mild development delay, mild mental re-
tardation, broad forehead, simplified ear helices, small mouth, 
and thin lips [11]. Partial trisomy of 12q24.33→qter with a 
1.3-Mb chromosome imbalance derived from a familial 
t(12;17)(q24.33;q25.3) showed only some mild phenotypic 
similarities with the features of the 12q duplication syndrome 
[12]. Sathanoori et al. [13] reported the smallest cryptic du-
plication (~423 kb) of 12q24.33→qter, in which about 37 
genes were found to be listed in the human genome data-
base (Ensembl v37). The genes included GOLGA3, CHFR, 
and zinc finger genes (ZNF605, ZNF26, ZNF84, ZNF140, 
ZNF10, and ZNF268). However, no important genes in the 
12q24.33→qter region were identified in our case.
In comparison with bacterial artificial chromosome (BAC) 
arrays, the high-resolution oligonucleotide arrays used in 
our case offer a much greater probe density for better detec-
tion of smaller genomic imbalances with a functional lower 
limit of 36 kb [14]. Thus, chromosomal alternations smaller 
than ~36 kb may be theoretically undetectable by array CGH 
(Agilent Technologies). In our case, even if the cryptic region 
of 12q is not detected by high-resolution array CGH, the 
chromosomal alterations would be considered benign or 
clinically insignificant because of the absence of recognizable 
phenotypic features of a partial duplication of 12q24.33→ 
qter in the karyotype. Moreover, a consensus statement for 
array CGH recently described that the smallest known re-
current pathogenic microdeletion syndromes are ~500 kb 
or larger [15], and array CGH, with a lower limit of resolu-
tion of ~400 kb throughout the genome, will reliably iden-
tify all known recurrent pathogenic microdeletion and mi-
croduplication syndromes [15, 16]. In addition, although 
cytogenetic events might appear to be balanced at the mi-
croscopic level of resolution, many such events have submi-
croscopic imbalances [17].
In our case, the MDS caused by a balanced translocation 
of t(12;17) was difficult to detect and would have gone un-
noticed without the previous history of recurrent lissen-
Fig. 4. Array comparative genomic hybridization ratio profile data for chromosomes 12 and 17 of the proband. Chromosome 12 shows no duplication or deletion 
on the q-arm (left). Chromosome 17 shows deletion (-4.6 Mb) on the p-arm (right).
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cephaly. The use of FISH on giemsa-trypsin-leishman (GTL) 
banded metaphase chromosomes (sequential G-banding 
and FISH) is effective for defining the cryptic translocation. 
Moreover, array CGH has enabled further delineation of 
the clinical spectrum of known chromosomal abnormali-
ties and the identification of novel, recurrent genetic imbal-
ances [18].
In summary, this is a rare MDS case derived from a pa-
rental balanced translocation confirmed by genomic array 
CGH and FISH. For this reason, the deletion of 17p in MDS 
in the proband should be not interpreted as a de novo dele-
tion without a parental study, especially in parents with a 
history of recurrent pregnancy loss. Accurate genetic coun-
seling can be offered to the family in cases where there is a 
potential risk of recurrent lissencephaly in the next preg-
nancy. The combined use of array CGH and FISH analysis 
is a powerful tool for the diagnosis of genetic diseases and 
can reveal unexpected genomic imbalances.
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